Skip to main content
Clinical Trials/NL-OMON48700
NL-OMON48700
Completed
Not Applicable

Tinnitus pitch matching by residual inhibition and contrast gain control. - Tinnitus pitch matching

niversitair Medisch Centrum Groningen0 sites60 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Tinnitus group (A, n\=20\):
  • \- No reported neurological or psychiatric disorders (excluding tinnitus and
  • hearing loss);
  • \- Chronic tinnitus (lasting more than 6 months);
  • \- Adult, 18\-75 years of age;
  • \- Symmetric hearing loss with PTA (average threshold 1000\-2000\-4000 Hz) \>\= 30 dB;
  • \- Written informed consent;
  • Hearing loss group (B, n\=20\):
  • \- No reported neurological or psychiatric disorders (excluding hearing loss);
  • \- Adult, 18\-75 years of age;

Exclusion Criteria

  • \- All subjects who cannot fully understand the experimental task.
  • \- Non\-conformance to any of the inclusion criteria stated above.

Outcomes

Primary Outcomes

Not specified

Similar Trials